Concord Drugs Ltd.

Financial

	Concord Drugs	Bacil Pharma	Medicamen Organics
Operational Metrics
Financials
5 yr Average ROE	3.38 %	-73.86 %	7.97 %
5yr average Equity Multiplier	1.86	1.72	3.29
5yr Average Asset Turnover Ratio	0.9	0.0	0.76
5yr Avg Net Profit Margin	1.88 %	0.0	3.89 %
Price to Book	1.64	2.12	0.0
P/E	166.67	133.51	15.56
5yr Avg Cash Conversion Cycle	260.53 Days	0.0	-32.99 Days
Inventory Days	138.17 Days	0.0	70.3 Days
Days Receivable	144.77 Days	0.0	198.36 Days
Days Payable	77.93 Days	23.71 Days	321.34 Days
5yr Average Interest Coverage Ratio	1.8	-950.16	3.25
5yr Avg ROCE	8.9 %	-81.01 %	15.06 %
5yr Avg Operating Profit Margin	9.09 %	0.0	9.86 %
5 yr average Debt to Equity	0.55	0.08	1.18
5yr CAGR Net Profit	-21.63 %	-28.45 %	51.57 %
5yr Average Return on Assets	1.77 %	-72.13 %	2.68 %
Shareholdings
Promoter Holding	54.39 %	0.2 %	59.73 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	5.39 %	-42.47 %	0.04 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0